Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 5:57 PM
Ignite Modification Date:
2025-12-24 @ 5:57 PM
NCT ID:
NCT02382068
Brief Summary:
This randomized pilot clinical trial studies dexamethasone in preventing hearing loss in patients receiving cisplatin. Injecting a steroid, such as dexamethasone, behind the eardrum before chemotherapy may help protect against cisplatin-associated hearing loss.
Detailed Description:
PRIMARY OBJECTIVES:
I. Investigate the potential protective effect of intratympanic dexamethasone administration on cisplatin-induced ototoxicity.
OUTLINE: Patients are randomized as to which ear receives dexamethasone.
Patients receive dexamethasone via intratympanic injection in one ear and placebo via intratympanic injection in the other ear.
After completion of study treatment, patients are followed up before each cisplatin treatment and then at 1 and 3 months after the last cisplatin treatment.
Study:
NCT02382068
Study Brief:
Protocol Section:
NCT02382068